Rate Video

VJVirtual | Cell-free DNA for multi-cancer detection

Geoffrey Oxnard • 9 Apr 2020

Breast Cancer General Genitourinary Cancer Gynecological Cancer Head and Neck Cancer Lung Cancer

Geoffrey Oxnard, MD, Dana-Farber Cancer Institute, Boston, MA, discusses the recent publication he co-authored in the Annals of Oncology around multi-detection of multiple cancer types using blood screening, and the next steps. This interview was recorded via an online conference call with The Video Journal of Oncology (VJOncology).

Cell-free DNA sequencing in the clinical setting

Geoffrey Oxnard • 28 Sep 2019

TATTON: Phase 1b trial of AZD9291 for EGFR-mutant lung cancer

Geoffrey Oxnard • 30 May 2015

CCGA: plasma cfDNA lung cancer screening

Geoffrey Oxnard • 1 Jun 2018

Impact of COVID-19 on scientific research and treating patients

Geoffrey Oxnard • 9 Apr 2020

Related Videos

TKIs to treat EGFRm-positive NSCLC

Marina Garassino

Overcoming the challenges of precision medicine in lung cancer

Giorgio Scagliotti

ALK-TKIs: targeted therapies for ALK-positive NSCLC

Antonio Passaro

PSMA vs AXUMIN PET/CT in prostate cancer